The Australian stock market recently saw the ASX200 dip slightly by 0.15%, influenced by geopolitical tensions in the Middle East, which impacted most sectors but boosted energy stocks. In this fluctuating environment, identifying growth companies with significant insider ownership can be crucial for investors seeking stability and potential upside, as such ownership often signals confidence from those closest to the company's operations.
Name | Insider Ownership | Earnings Growth |
Clinuvel Pharmaceuticals (ASX:CUV) | 10.4% | 27.4% |
Catalyst Metals (ASX:CYL) | 17% | 54.5% |
Genmin (ASX:GEN) | 12% | 117.7% |
Hillgrove Resources (ASX:HGO) | 10.4% | 70.9% |
AVA Risk Group (ASX:AVA) | 15.7% | 118.8% |
Pointerra (ASX:3DP) | 18.7% | 126.4% |
Liontown Resources (ASX:LTR) | 16.4% | 49.8% |
Acrux (ASX:ACR) | 17.4% | 91.6% |
Adveritas (ASX:AV1) | 21.1% | 144.2% |
Plenti Group (ASX:PLT) | 12.8% | 106.4% |
Click here to see the full list of 101 stocks from our Fast Growing ASX Companies With High Insider Ownership screener.
Underneath we present a selection of stocks filtered out by our screen.
Simply Wall St Growth Rating: ★★★★★★
Overview: Liontown Resources Limited focuses on the exploration, evaluation, and development of mineral properties in Australia with a market cap of A$1.95 billion.
Operations: Revenue segments for Liontown Resources Limited are not specified in the provided text.
Insider Ownership: 16.4%
Liontown Resources, a growth company with high insider ownership in Australia, recently appointed Ian Wells as Lead Independent Director to enhance corporate governance. Despite reporting a net loss of A$64.92 million for the year ended June 30, 2024, Liontown's revenue is forecasted to grow at 40% annually. The strategic partnership with LG Energy Solution includes a US$250 million investment and extended offtake agreements, bolstering long-term value creation and production ramp-up at the Kathleen Valley Project.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Mineral Resources Limited, with a market cap of A$10.25 billion, operates as a mining services company in Australia, Asia, and internationally through its subsidiaries.
Operations: The company's revenue segments include A$16 million from Energy, A$1.41 billion from Lithium, A$2.58 billion from Iron Ore, and A$3.38 billion from Mining Services, along with A$19 million from Other Commodities.
Insider Ownership: 11.7%
Mineral Resources, backed by billionaire Chris Ellison, is exploring asset sales to strengthen its balance sheet amid high net debt. Recent M&A discussions involve potential buyers for its Perth Basin assets. Despite earnings and profit margin declines, the company forecasts significant annual earnings growth of 38.3%, outpacing the Australian market. Insiders have shown confidence with more shares bought than sold recently, though not in substantial volumes, highlighting insider ownership's influence on strategic decisions.
Simply Wall St Growth Rating: ★★★★★☆
Overview: Mesoblast Limited develops regenerative medicine products across Australia, the United States, Singapore, and Switzerland, with a market cap of A$1.42 billion.
Operations: The company's revenue segment focuses on the development of its cell technology platform for commercialization, generating $5.90 million.
Insider Ownership: 22.2%
Mesoblast is experiencing significant insider buying, indicating confidence in its growth prospects. Despite being dropped from the S&P/ASX Emerging Companies Index, it remains undervalued at 94.2% below estimated fair value and forecasts suggest robust revenue growth of 45.8% annually, outpacing the market. However, financial challenges persist with a net loss reported and less than one year of cash runway available. The potential FDA approval for Ryoncil could be pivotal for future profitability and market position improvement.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Companies discussed in this article include ASX:LTR ASX:MIN and ASX:MSB.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。